BACKGROUND: Previous work has found a high prevalence of pulmonary arterial hypertension in HIV-infected persons, but establishment of a causal relationship has been limited by the lack of well characterized contemporaneous HIV-uninfected comparator groups. Among HIV-uninfected persons, human herpesvirus-8 (HHV-8) has also been linked to pulmonary arterial hypertension (PAH), but whether this relationship occurs among HIV-infected persons - who have among the highest prevalence of HHV-8 infection - has not been examined. METHODS AND RESULTS: We echocardiographically calculated pulmonary artery systolic pressure and measured HHV-8 antibodies in HIV-infected and HIV-uninfected adults. Among the 196 HIV-infected participants, the median pulmonary artery systolic pressure (PASP) was 27.5 mmHg and 35.2% had PASP greater than 30 mmHg. This compared to a median of 22 mmHg among 52 HIV-uninfected participants in whom 7.7% had a PASP greater than 30 mmHg (P < 0.001). After adjustment for injecting drug and stimulant use, smoking, age, and gender, HIV-infected participants had 5.1 mmHg higher mean PASP and seven fold greater odds of having a PASP greater than 30 mmHg (P < 0.001). Although we found no association between HHV-8 and PAH among all HIV-infected participants, a borderline relationship was present when restricting to those without risk factors for PAH. CONCLUSION: HIV-infected persons have a high prevalence of elevated PASP, which is independent of other risk factors for PAH. This suggests a causal role of HIV in PAH and emphasizes the need to understand the natural history of PAH in this setting. A role for HHV-8 infection in PAH remains much less definitive.
BACKGROUND: Previous work has found a high prevalence of pulmonary arterial hypertension in HIV-infectedpersons, but establishment of a causal relationship has been limited by the lack of well characterized contemporaneous HIV-uninfected comparator groups. Among HIV-uninfectedpersons, human herpesvirus-8 (HHV-8) has also been linked to pulmonary arterial hypertension (PAH), but whether this relationship occurs among HIV-infectedpersons - who have among the highest prevalence of HHV-8 infection - has not been examined. METHODS AND RESULTS: We echocardiographically calculated pulmonary artery systolic pressure and measured HHV-8 antibodies in HIV-infected and HIV-uninfected adults. Among the 196 HIV-infectedparticipants, the median pulmonary artery systolic pressure (PASP) was 27.5 mmHg and 35.2% had PASP greater than 30 mmHg. This compared to a median of 22 mmHg among 52 HIV-uninfectedparticipants in whom 7.7% had a PASP greater than 30 mmHg (P < 0.001). After adjustment for injecting drug and stimulant use, smoking, age, and gender, HIV-infectedparticipants had 5.1 mmHg higher mean PASP and seven fold greater odds of having a PASP greater than 30 mmHg (P < 0.001). Although we found no association between HHV-8 and PAH among all HIV-infectedparticipants, a borderline relationship was present when restricting to those without risk factors for PAH. CONCLUSION:HIV-infectedpersons have a high prevalence of elevated PASP, which is independent of other risk factors for PAH. This suggests a causal role of HIV in PAH and emphasizes the need to understand the natural history of PAH in this setting. A role for HHV-8 infection in PAH remains much less definitive.
Authors: L Abenhaim; Y Moride; F Brenot; S Rich; J Benichou; X Kurz; T Higenbottam; C Oakley; E Wouters; M Aubier; G Simonneau; B Bégaud Journal: N Engl J Med Date: 1996-08-29 Impact factor: 91.245
Authors: H Rakowski; C Appleton; K L Chan; J G Dumesnil; G Honos; J Jue; C Koilpillai; S Lepage; R P Martin; L A Mercier; B O'Kelly; T Prieur; A Sanfilippo; Z Sasson; N Alvarez; R Pruitt; C Thompson; C Tomlinson Journal: J Am Soc Echocardiogr Date: 1996 Sep-Oct Impact factor: 5.251
Authors: H Ehrenreich; P Rieckmann; F Sinowatz; K A Weih; L O Arthur; F D Goebel; P R Burd; J E Coligan; K A Clouse Journal: J Immunol Date: 1993-05-15 Impact factor: 5.422
Authors: M Patricia George; Hunter C Champion; Mark T Gladwin; Karen A Norris; Alison Morris Journal: Am J Respir Crit Care Med Date: 2012-06-01 Impact factor: 21.405
Authors: Matthew R Gingo; Mehdi Nouraie; Cathy J Kessinger; Ruth M Greenblatt; Laurence Huang; Eric C Kleerup; Lawrence Kingsley; Deborah K McMahon; Alison Morris Journal: Ann Am Thorac Soc Date: 2018-02
Authors: Zian H Tseng; Eric A Secemsky; David Dowdy; Eric Vittinghoff; Brian Moyers; Joseph K Wong; Diane V Havlir; Priscilla Y Hsue Journal: J Am Coll Cardiol Date: 2012-05-22 Impact factor: 24.094
Authors: Sharilyn Almodovar; Rob Knight; Amanda A Allshouse; Sarah Roemer; Catherine Lozupone; Daniel McDonald; Jeremy Widmann; Norbert F Voelkel; Robert J Shelton; Edu B Suarez; Kenneth W Hammer; Cecile Goujard; Nicola Petrosillo; Gerald Simonneau; Priscilla Y Hsue; Marc Humbert; Sonia C Flores Journal: AIDS Res Hum Retroviruses Date: 2012-01-17 Impact factor: 2.205
Authors: Brian S Moyers; Eric A Secemsky; Eric Vittinghoff; Joseph K Wong; Diane V Havlir; Priscilla Y Hsue; Zian H Tseng Journal: Am J Cardiol Date: 2014-01-16 Impact factor: 2.778
Authors: Matthew R Gingo; Jiayan He; Catherine Wittman; Carl Fuhrman; Joseph K Leader; Cathy Kessinger; Lorrie Lucht; William A Slivka; Yingze Zhang; Deborah K McMahon; Frank C Sciurba; Alison Morris Journal: Eur Respir J Date: 2013-02-21 Impact factor: 16.671
Authors: Rushi V Parikh; Rebecca Scherzer; Elaine M Nitta; Anna Leone; Sophia Hur; Vanita Mistry; John S Macgregor; Jeffrey N Martin; Steven G Deeks; Peter Ganz; Priscilla Y Hsue Journal: AIDS Date: 2014-02-20 Impact factor: 4.177